Combined oropharyngeal nasal (ON) swabs for the molecular detection of respiratory pathogens including M. pneumoniae in symptomatic children
Microbiology Spectrum · 07.10.2025 · 13 (10)
DOI: 10.1128/spectrum.02181-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 07.10.2025. Verfasst von Hannah Nelson und 15 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Medicine Graduate Program, University of British Columbia, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Oropharynx, Mycoplasma pneumoniae, Specimen Handling, Respiratory Tract Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Columbia Ministry of Health Innovation Pathway Program, BC Children's Hospital Foundation (British Columbia Children's Hospital Foundation), Health Canada Safe Restart Agreement.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
This study aimed to evaluate the diagnostic yield and acceptability of parent-/caregiver-collected oropharyngeal nasal (ON) swabs compared with healthcare worker (HCW)-collected nasopharyngeal (NP) swabs for detecting respiratory viruses and Mycoplasma pneumoniae in children. Symptomatic children (0–4 years) presenting to the BC Children’s Hospital Emergency Department provided HCW-collected NP and caregiver-collected ON swabs. Acceptability was assessed using a 5-point Likert scale. Samples were tested using the SARS-CoV-2/Influenza A + B/RSV GeneXpert assay, and a subset was tested on the BioFire respiratory panel (RP) 2.1 during the initial research phase. In a subsequent implementation phase during a high incidence of M. pneumoniae , paired ON and NP swabs were collected and tested on the RP 2.1 in a quality improvement initiative. All M. pneumoniae -positive samples underwent testing for cycle threshold values. We analyzed 139 pairs from the research phase and 219 from the implementation phase. Detection rates for SARS-CoV-2, influenza A/B, and RSV were similar across swab types. Of 273 pairs tested on BioFire, ON swabs demonstrated significantly higher detection of M. pneumoniae (sensitivity of 94%, confidence interval [CI] [86, 98] ON vs 64% [61–75] NP, P = 0.0020) and comparable detection for other pathogens. Caregivers rated ON swab collection as more acceptable than NP swabs (median 4.5 [4–5] vs 2 [IQR 1–3], P < 0.0001). ON swab performance was similar to NP swabs for the detection of respiratory viruses and showed improved diagnostic yield of M. pneumoniae . Given their higher acceptability ratings, ON swabs should be considered as a less-invasive diagnostic option for children. IMPORTANCE The current clinical standard for diagnosing respiratory infections in children typically requires a nasopharyngeal (NP) swab, which may be uncomfortable for the patient and must be collected by a healthcare worker. This study presents a less-invasive option, an oropharyngeal nasal (ON) swab collected by a parent or caregiver, that has comparable detection for common respiratory viruses and improved detection for Mycoplasma pneumoniae , a common but treatable cause of childhood pneumonia. Additionally, parents/caregivers rated ON swabs as significantly more acceptable than NP swabs on a scale of 1 to 5. Given the increased acceptability and superior detection of treatable M. pneumoniae , ON swabs are a patient-centered alternative to NP swabs and should be considered as a preferred diagnostic option for children.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Experimental Medicine Graduate Program, University of British Columbia, Vancouver, British Columbia, Canada.
- BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.
- Department of Pathology and Laboratory Medicine, BC Children's and Women's Hospital & Health Centre, Vancouver, British Columbia, Canada.
- Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada.
- Community Based Testing and Biomedical Initiatives, First Nations Health Authority, Vancouver, British Columbia, Canada.
- Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.
ORCID-Profile: Hannah Nelson, Mai-Lei Woo Kinshella, David M Goldfarb
Förderung
- British Columbia Ministry of Health Innovation Pathway Program
- BC Children's Hospital Foundation (British Columbia Children's Hospital Foundation)
- Health Canada Safe Restart Agreement
Zitieren
APA
Nelson, H., Kayda, I., Watson, N., Kinshella, M. L. W., Cochrane, J., Desai, N., Dittrick, M., Hoang, L., Hawkes, M. T., Meckler, G., Sabhaney, V., Gubbay, J. B., Imperial, M., Srigley, J. A., Li, L., & Goldfarb, D. M. (2025). Combined oropharyngeal nasal (ON) swabs for the molecular detection of respiratory pathogens including M. pneumoniae in symptomatic children. Microbiology Spectrum, 13(10). https://doi.org/10.1128/spectrum.02181-25
Vancouver
Nelson H, Kayda I, Watson N, Kinshella MLW, Cochrane J, Desai N, et al. Combined oropharyngeal nasal (ON) swabs for the molecular detection of respiratory pathogens including M. pneumoniae in symptomatic children. Microbiology Spectrum. 2025;13(10). doi:10.1128/spectrum.02181-25
BibTeX
@article{Nelson2025,
author = {Nelson, Hannah and Kayda, Iryna and Watson, Nicole and Kinshella, Mai-Lei Woo and Cochrane, Jennifer and Desai, Neil and Dittrick, Michelle and Hoang, Linda and Hawkes, Michael T and Meckler, Garth and Sabhaney, Vikram and Gubbay, Jonathan B and Imperial, Miguel and Srigley, Jocelyn A and Li, Lynne and Goldfarb, David M},
title = {Combined oropharyngeal nasal (ON) swabs for the molecular detection of respiratory pathogens including M. pneumoniae in symptomatic children},
journal = {Microbiology Spectrum},
year = {2025},
volume = {13},
number = {10},
doi = {10.1128/spectrum.02181-25}
}
EUVIMED